University of Birmingham
Birmingham, West Midlands, B18 4DA, United Kingdom
NCT Number: NCT01145820
The proposed study will test the following hypotheses:
1. Pre-operative daily dual supplementation with Juice Plus+ (fruit & vegetable) for 11 weeks will result in reduced post-operative morbidity in terms of quality of life, pain and trismus after 1 week following surgical removal of lower third molars, when compared to placebo. 2. Pre-operative daily dual supplementation with Juice Plus+ (fruit & vegetable) for 11 weeks will reduce serum markers of oxidative stress, following surgical removal of lower third molars, when compared with placebo.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Birmingham, West Midlands, B18 4DA, United Kingdom
In general antioxidant status appears to influence wound healing in humans and in animal models of acute trauma, with low antioxidant concentrations and excessive oxidative stress being associated with impaired healing. Whilst antioxidant supplementation has been reported to improve plasma antioxidant status and wound healing in animal models of acute trauma, there is remarkably little data from human studies.
The use of Juice Plus+ has been reported to increase serum concentrations of important antioxidants and reduce serum markers of oxidative stress. However, to date there are no reported studies concerning the potential for Juice Plus+ to improve patient-based outcome measures following the surgical removal of lower third molars. This study therefore proposes to investigate the impact of daily supplementation with Juice Plus+, in improving outcomes following surgical trauma. While the rationale for the proposed study is primarily predicated on the established role of oxidative stress and antioxidant micronutrients in chronic inflammatory diseases, the proposed randomized controlled clinical study represents an efficient way of evaluating the potential for adjunctive Juice Plus+ use in improving wound healing and reducing post-operative morbidity following surgical procedures on humans.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Juice Plus (2 capsules bds) for 11 weeks (10 weeks preop and 1 week postop)
Time frame: first postoperative week
QOL as assessed by PoSSe scale (Ruta et al., 2000)
Time frame: postoperative week
trismus will be assessed by investigator at 48h and 1 week postoperative, and every postop day by patient
Time frame: postoperative week
pain will be assessed by patient on VAS on each postop day. groups will be compared for the following:
Time frame: first postoperative week
Time frame: baseline (preop) and 1 week postop
group differences between plasma TAOC changes between baseline and 1 week postop
Time frame: first postoperative week (baseline and 1 week)
differences in change from baseline to 1 week of mean protein carbonyls, isoprostanes and 8OHdG
Time frame: first postoperative week
change between baseline and 1 week of: CRP, fibrinogen, WBC
Time frame: first postoperative week
University of Birmingham
Other
Efficacy of Adjunctive Juice Plus in Reducing Post-operative Morbidity and Improving Quality of Life After Lower Third Molar Surgery: a Randomized Controlled Clinical Trial
Acronym: FAVOURITE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03987789
Emergency Abdominal Surgery, General Anesthesia
Angers, France
View Trial DetailsNCT01515670
Arthroplasty Complications, Co-morbidity
Farsø, Judland, Denmark
View Trial DetailsNCT03420261
Hemostasis Change, Postoperative Morbidity
Clermont-Ferrand, France
View Trial DetailsNCT02502773
Postoperative Morbidity, Postoperative Mortality
Clermont-Ferrand, France
View Trial Details